Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis

被引:30
作者
Radecke, K [1 ]
Frühauf, NR [1 ]
Miller, M [1 ]
Ross, B [1 ]
Köditz, R [1 ]
Malagó, M [1 ]
Broelsch, CE [1 ]
Gerken, G [1 ]
Treichel, U [1 ]
机构
[1] Univ Hosp Essen, Dept Gastroenterol & Hepatol, D-45147 Essen, Germany
关键词
end-stage liver disease; HIV infection; HIV/HBV co-infection; HIV; HCV co-infection; liver transplantation;
D O I
10.1111/j.1478-3231.2005.01031.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: We report on our experiences with orthotopic liver transplantation (OLT) in HIV-infected patients. Between July 1998 and October 2001, five HIV-infected patients underwent OLT because of virus-induced liver cirrhosis. One patient suffered from hepatitis B virus (HBV)-, three patients from hepatitis C virus (HCV)- and one patient from HCV/HBV/HDV-related cirrhosis (HDV, hepatitis D virus). The mean duration of HIV infection was 15 years. Patients were prospectively followed up with a mean duration of 25.6 months. Results: Three patients died 3, 10 and 31 months after OLT, respectively, due to graft failure. The causes of graft failure were: recurrent thrombosis of the hepatic artery, HCV-associated cholestatic hepatitis and chemotherapy-induced liver damage due to Hodgkin's disease, which was diagnosed 17 months after OLT, in addition to chronic HCV disease. The two survivors show a stable liver function and non-progredient HIV infection under antiretroviral therapy 61 and 23 months after OLT, respectively. Conclusions: A medium- or even long-term survival after OLT can be achieved in HIV-infected patients without progression of HIV disease under antiretroviral therapy. However, in our study three out of five patients died due to graft failure. Therefore, prognostic criteria have to be defined for the selection of HIV-infected patients, who may benefit from OLT.
引用
收藏
页码:101 / 108
页数:8
相关论文
共 46 条
[1]   Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: A case-control study [J].
Allory, Y ;
Charlotte, F ;
Benhamou, Y ;
Opolon, P ;
Le Charpentier, Y ;
Poynard, T .
HUMAN PATHOLOGY, 2000, 31 (01) :69-74
[2]   Aids-related malignancies [J].
Boshoff, C ;
Weiss, R .
NATURE REVIEWS CANCER, 2002, 2 (05) :373-382
[3]   AN OBSERVATIONAL STUDY OF 11 FRENCH LIVER-TRANSPLANT RECIPIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
BOUSCARAT, F ;
SAMUEL, D ;
SIMON, F ;
DEBAT, P ;
BISMUTH, H ;
SAIMOT, AG .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (05) :854-859
[4]   Successful cardiac transplantation in an HIV-1-infected patient with advanced disease [J].
Calabrese, LH ;
Albrecht, M ;
Young, J ;
McCarthy, P ;
Haug, M ;
Jarcho, J ;
Zackin, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (23) :2323-2328
[5]   Long-term outcome of hepatitis C infection after liver transplantation [J].
Cane, EJ ;
Portmann, BC ;
Naoumov, NV ;
Smith, HM ;
Underhill, JA ;
Donaldson, PT ;
Maertens, G ;
Williams, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (13) :815-820
[6]   Hepatitis C infection in liver transplantation [J].
Charlton, M .
AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (03) :197-203
[7]  
DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
[8]   Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation [J].
Dickson, RC ;
Caldwell, SH ;
Ishitani, MB ;
Lau, JYN ;
Driscoll, CJ ;
Stevenson, WC ;
McCullough, CS ;
Pruett, TL .
TRANSPLANTATION, 1996, 61 (05) :701-705
[9]   INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS IN THE PITTSBURGH TRANSPLANT POPULATION - A STUDY OF 583 DONORS AND 1043 RECIPIENTS, 1981-1986 [J].
DUMMER, JS ;
ERB, S ;
BREINIG, MK ;
HO, M ;
RINALDO, CR ;
GUPTA, P ;
RAGNI, MV ;
TZAKIS, A ;
MAKOWKA, L ;
VANTHIEL, D ;
STARZL, TE .
TRANSPLANTATION, 1989, 47 (01) :134-139
[10]  
ERICE A, 1991, REV INFECT DIS, V13, P537